Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases

Wynn TA . Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199–210.

Desmouliere A, Darby IA, Gabbiani G . Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003; 83: 1689–1707.

Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180: 1340–1355.

Sugimoto H, Mundel TM, Kieran MW, Kalluri R . Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5: 1640–1646.

Wynn TA . Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339–1350.

Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1807–1816.

Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85–97.

Kalluri R, Neilson EG . Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776–1784.

Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890.

Piera-Velazquez S, Li Z, Jimenez SA . Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074–1080.

Friedman SL . Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655–1669.

Gabbiani G . The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500–503.

Gressner OA, Weiskirchen R, Gressner AM . Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007; 6: 7.

Trautwein C, Friedman SL, Schuppan D, Pinzani M . Hepatic fibrosis: concept to treatment. J Hepatol 2015; 62: S15–S24.

Wynn TA, Ramalingam TR . Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18: 1028–1040.

Agarwal SK . Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol 2014; 5: 131.

Henderson NC, Sheppard D . Integrin-mediated regulation of TGFbeta in fibrosis. Biochim Biophys Acta 2013; 1832: 891–896.

Humphries JD, Byron A, Humphries MJ . Integrin ligands at a glance. J Cell Sci 2006; 119: 3901–3903.

Hynes RO . Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673–687.

Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013; 19: 1617–1624.

Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319–328.

Popova SN, Lundgren-Akerlund E, Wiig H, Gullberg D . Physiology and pathology of collagen receptors. Acta Physiol (Oxf) 2007; 190: 179–187.

Tiger CF, Fougerousse F, Grundstrom G, Velling T, Gullberg D . α11β1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol 2001; 237: 116–129.

Popova SN, Rodriguez-Sanchez B, Liden A, Betsholtz C, Van Den Bos T, Gullberg D . The mesenchymal alpha11beta1 integrin attenuates PDGF-BB-stimulated chemotaxis of embryonic fibroblasts on collagens. Dev Biol 2004; 270: 427–442.

Talior-Volodarsky I, Connelly KA, Arora PD, Gullberg D, McCulloch CA . α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy. Cardiovasc Res 2012; 96: 265–275.

Honda E, Yoshida K, Munakata H . Transforming growth factor-beta upregulates the expression of integrin and related proteins in MRC-5 human myofibroblasts. Tohoku J Exp Med 2010; 220: 319–327.

Lu N, Carracedo S, Ranta J, Heuchel R, Soininen R, Gullberg D . The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner. Matrix Biol 2010; 29: 166–176.

Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, Gullberg D . The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem 2010; 285: 10434–10445.

Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ et al. Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. Oncogene 2016; 35: 1899–1908.

Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci USA 2010; 107: 8352–8356.

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15–20.

Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015; 16: 51–66.

Inagaki Y, Okazaki I . Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284–292.

Margadant C, Sonnenberg A . Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 2010; 11: 97–105.

Hu L, Lin X, Lu H, Chen B, Bai Y . An overview of hedgehog signaling in fibrosis. Mol Pharmacol 2015; 87: 174–182.

Olinga P, Schuppan D . Precision-cut liver slices: a tool to model the liver ex vivo. J Hepatol 2013; 58: 1252–1253.